(Q39383409)

11 September 2017

Effectiveness of eletriptan in acute migraine: primary care for Excedrin nonresponders (English)

1 reference

11 September 2017

1 reference

1 reference

Merle L Diamond

1

1 reference

11 September 2017

Jayasena Hettiarachchi

2

1 reference

11 September 2017

Barbara Hilliard

3

1 reference

11 September 2017

George Sands

4

1 reference

11 September 2017

Robert Nett

5

1 reference

11 September 2017

1 March 2004

1 reference

11 September 2017

1 reference

11 September 2017

44

1 reference

11 September 2017

209-216

1 reference

11 September 2017

3

1 reference

Migraine in the United States: epidemiology and patterns of health care use.

11 September 2017

1 reference

https://api.crossref.org/works/10.1111%2FJ.1526-4610.2004.04049.X

Practice parameter: evidence-based guidelines for migraine headache (an evidence-based review): report of the Quality Standards Subcommittee of the American Academy of Neurology

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1526-4610.2004.04049.X

Eletriptan in acute migraine: a double-blind, placebo-controlled comparison to sumatriptan. Eletriptan Steering Committee.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1526-4610.2004.04049.X

Eletriptan vs sumatriptan: a double-blind, placebo-controlled, multiple migraine attack study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1526-4610.2004.04049.X

Comparison of rizatriptan and other triptans on stringent measures of efficacy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1526-4610.2004.04049.X

Features of medication overuse headache following overuse of different acute headache drugs.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1526-4610.2004.04049.X

10.1111/J.1526-4610.2004.04049.X

21 January 2018

Identifiers

DOI

1 reference

11 September 2017

1 reference